In 2020, CeMM has founded two spin-off companies: Proxygen and Solgate. In total, CeMM is the founding partner of six spin-off companies.
CeMM is constantly striving to create and maintain an entrepreneurship environment for our scientists so they can focus on achieving maximum scientific innovation to improve healthcare. CeMM promotes and supports the generation of new business opportunities arising from the innovative ideas from our leading scientists and their research projects.
Find out more about our spin-offs: